• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Six Months Ended April 30, 2022

    10/27/22 4:30:00 PM ET
    $TIRX
    Specialty Insurers
    Finance
    Get the next $TIRX alert in real time by email

    BEIJING, Oct. 27, 2022 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, announced today its unaudited financial results for the six months ended April 30, 2022.

    Mr. Zhe Wang, Chairman of the board of the directors and Chief Executive Officer of the Company, commented, "The challenging macro environment and disruptions caused by the ongoing regional Covid-19 pandemic restrictions in China has impacted our business. Our revenue decreased by 42.2% for the six months ended April 30, 2022, which was primarily attributable to a significant decrease in the commissions from liability insurance. We executed our strategy to expand our business in commercial property insurance and other insurances to partially offset the decrease in the revenue from liability insurance. We plan to continue attracting new customers and strengthening our relationship with existing customers through our dedicated sales team and high-quality customer services. Looking forward, we remain committed in our business strategy to expand our market share and growth opportunities in the insurance industry in China, while improving our operational efficacy to achieve sustainable development goal and provide long-term returns to our shareholders."

    First Half of Fiscal Year 2022 Financial Highlights



    For the Six Months Ended April 30,

    ($ in millions, except per share data)

    2022



    2021



    % Change

    Revenue

    0.95



    1.64



    (42.2) %

    Operating expenses

    4.83



    2.10



    129.6 %

    Loss from operations

    (3.88)



    (0.47)



    733.6 %

    Net loss

    (3.50)



    (0.40)



    767.4 %

    Loss per share

    (0.28)



    (0.06)



    366.7 %

     

    • Revenue decreased by 42.2% to $0.95 million for the six months ended April 30, 2022, from $1.64 million for the same period of fiscal year 2021, primarily attributable to a significant decrease in commission from liability insurance of approximately $1.03 million resulting from the loss of insurance company partners, offset by an increase in commission from commercial property insurance of approximately $0.25 million driven by our business expansion and an increase in commission from other miscellaneous insurances of approximately $0.09 million.
    • Operating expenses increased by 129.6% to $4.83 million for the six months ended April 30, 2022, from $2.10 million for the same period of fiscal year 2021.
    • Net loss was $3.50 million for the six months ended April 30, 2022, compared to $0.40 million for the same period of fiscal year 2021.
    • Loss per share was $0.28 for the six months ended April 30, 2022, compared to $0.06 for the same period of fiscal year 2021.

    First Half of Fiscal Year 2022 Financial Results

    Revenue

    Revenue decreased by $0.69 million, or 42.2% to $0.95 million for the six months ended April 30, 2022, from $1.64 million for the same period of fiscal year 2021. This decrease was primarily attributable to a significant decrease in commission from liability insurance of approximately $1.03 million resulting from the loss of insurance company partners, offset by an increase in commission from commercial property insurance of approximately $0.25 million driven by our business expansion and an increase in commission from other miscellaneous insurances of approximately $0.09 million.

    Operating Expenses

    Third party and related party selling and marketing expenses increased by $0.25 million, or 29.6%, to $1.11 million for the six months ended April 30, 2022, from $0.86 million for the same period of fiscal year 2021. The increase was mainly attributable to an increase in the stock-based compensation of approximately $0.58 million which reflected the value of our ordinary shares granted to our sales professionals, offset by a decrease in marketing fees of approximately $0.33 million due to our decreased marketing activities.

    Third party and related party general and administrative expenses increased by $2.47 million, or 198.7%, to $3.71 million for the six months ended April 30, 2022, from $1.24 million for the same period of fiscal year 2021. The increase in general and administrative expenses was primarily attributable to the increased professional fees, compensation and related benefits, rent and related utilities, directors and officers' liability insurance premium expenses, and partially offset by the decreased travel and entertainment, and depreciation and amortization expenses.

    Total operating expenses increased by $2.72 million, or 129.6%, to $4.83 million for the six months ended April 30, 2022, from $2.10 million for the same period of fiscal year 2021.

    Loss from Operations

    Loss from operations was $3.88 million for the six months ended April 30, 2022, compared to $0.47 million for the same period of fiscal year 2021.

    Other Income

    Other income primarily includes interest income generated by notes receivable and miscellaneous income. Other income, net, was $0.40 million for the six months ended April 30, 2022, compared to $0.07 million for the same period of fiscal year 2021.

    Loss before Income Tax

    Loss before income tax was $3.48 million for the six months ended April 30, 2022, compared to $0.40 million for the same period of fiscal year 2021.

    Income tax expense was $21,410 for the six months ended April 30, 2022, compared to $6,917 for the same period of fiscal year 2021.

    Net Loss and Net Loss per Share

    Net loss was $3.50 million for the six months ended April 30, 2022, compared to $0.40 million for the same period of fiscal year 2021. After deduction of non-controlling interest, net loss attributable to TIRX ordinary shareholders was $3.50 million, or net loss per share of $0.28 for the six months ended April 30, 2022, compared to $0.40 million, or net loss per share of $0.06 for the same period of fiscal year 2021.

    Financial Conditions

    At April 30, 2022, the Company had cash and cash equivalents of $29.02 million, compared to $30.02 million at October 31, 2021. Total working capital was $36.52 million at April 30, 2022, compared to $30.51 million at October 31, 2021.

    Net cash used in operating activities was $0.08 million for the six months ended April 30, 2022, compared to net cash provided by operating activities of $1.09 million for the same period of fiscal year 2021.

    Net cash used in investing activities was $2,436 for the six months ended April 30, 2022, and there were no investing activities for the same period of fiscal year 2021.

    Net cash flow provided by financing activities was $0 for the six months ended April 30, 2022, and net cash provided by financing activities was $10.71 million for the same period of fiscal year 2021.

    About TIAN RUIXIANG Holdings Ltd

    TIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker operating in China through its China-based variable interest entity. It distributes a wide range of insurance products, which are categorized into two major groups: (1) property and casualty insurance, such as automobile insurance, commercial property insurance, liability insurance; and (2) other insurance, such as life insurance and health insurance. For more information, visit the company's website at http://ir.tianrx.com/.

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review risk factors that may affect its future results in the Company's registration statement and in its other filings with the SEC.

    For investor and media enquiries, please contact:

    TIAN RUIXIANG Holdings Ltd

    Investor Relations Department

    Email: [email protected] 

    Ascent Investor Relations LLC

    Tina Xiao

    Phone: +1 917-609-0333

    Email: [email protected] 

     

     

    TIAN RUIXIANG HOLDINGS LTD AND SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (IN U.S. DOLLARS)





    As of





    April 30, 2022



    October 31, 2021

    ASSETS



     (Unaudited)





















    CURRENT ASSETS:













    Cash and cash equivalents



    $

    29,015,368



    $

    30,024,372

    Restricted cash





    795,044





    819,269

    Accounts receivable





    97,404





    320,848

    Note receivable





    7,500,000





    —

    Interest receivable





    186,986





    —

    Due from related party





    2,485





    —

    Other current assets





    245,007





    465,650















    Total Current Assets





    37,842,294





    31,630,139















    NON-CURRENT ASSETS:













    Note receivable





    —





    7,500,000

    Interest receivable





    —





    113,014

    Property and equipment, net





    10,825





    11,265

    Intangible assets, net





    133,404





    147,538

    Right-of-use assets, operating leases, net





    486,854





    760,229

    Other non-current assets





    90,807





    188,281















    Total Non-current Assets





    721,890





    8,720,327















    Total Assets



    $

    38,564,184



    $

    40,350,466















    LIABILITIES AND EQUITY



























    CURRENT LIABILITIES:













    Taxes payable



    $

    499,094



    $

    493,196

    Salary payable





    207,301





    103,168

    Accrued liabilities and other payables





    275,600





    95,664

    Due to related party





    —





    2,564

    Operating lease liabilities





    343,547





    423,124















    Total Current Liabilities





    1,325,542





    1,117,716















    NON-CURRENT LIABILITIES:













    Operating lease liabilities - noncurrent portion





    106,551





    237,848















    Total Non-current Liabilities





    106,551





    237,848















    Total Liabilities





    1,432,093





    1,355,564















    EQUITY:













    TIAN RUIXIANG Holdings Ltd Shareholders' Equity:













    Ordinary shares: $0.001 par value; 50,000,000 shares authorized;













    Class A ordinary shares: $0.001 par value; 47,500,000 shares authorized; 12,236,000 and 10,100,000 shares issued and outstanding

    at April 30, 2022 and October 31, 2021 respectively





    12,236





    10,100

    Class B ordinary shares: $0.001 par value; 2,500,000 shares authorized; 1,250,000 shares issued and outstanding at April 30, 2022

    and October 31, 2021





    1,250





    1,250

    Additional paid-in capital





    42,363,453





    39,776,761

    Less: ordinary stock held in treasury, at cost; 450,000 and 0 shares at April 30, 2022 and October 31, 2021 respectively





    —





    —

    Accumulated deficit





    (4,593,767)





    (1,090,060)

    Statutory reserve





    199,653





    199,653

    Accumulated other comprehensive (loss) income





    (851,189)





    96,709

    Total TIAN RUIXIANG Holdings Ltd shareholders'equity





    37,131,636





    38,994,413

    Non-controlling interest





    455





    489















    Total Equity





    37,132,091





    38,994,902















    Total Liabilities and Equity



    $

    38,564,184



    $

    40,350,466

     

     

    TIAN RUIXIANG HOLDINGS LTD AND SUBSIDIARIES

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

    (IN U.S. DOLLARS)







    For the Six Months Ended April 30,





    2022



    2021















    REVENUE



    $

    945,645



    $

    1,636,835















    OPERATING EXPENSES













    Selling and marketing





    1,113,896





    859,388

    General and administrative - professional fees





    930,873





    656,534

    General and administrative - compensation and related benefits





    2,346,067





    424,225

    General and administrative - other





    435,233





    162,183















    Total Operating Expenses





    4,826,069





    2,102,330















    LOSS FROM OPERATIONS





    (3,880,424)





    (465,495)















    OTHER INCOME













    Interest income





    75,326





    1,038

    Other income





    322,781





    67,438















    Total Other Income





    398,107





    68,476















    LOSS BEFORE INCOME TAXES





    (3,482,317)





    (397,019)















    INCOME TAXES





    21,410





    6,917















    NET LOSS



    $

    (3,503,727)



    $

    (403,936)















    LESS: NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST





    (20)





    (1)















    NET LOSS ATTRIBUTABLE TO TIAN RUIXIANG HOLDINGS LTD ORDINARY

    SHAREHOLDERS



    $

    (3,503,707)



    $

    (403,935)















    COMPREHENSIVE LOSS:













    NET LOSS





    (3,503,727)





    (403,936)

    OTHER COMPREHENSIVE (LOSS) INCOME













    Unrealized foreign currency translation (loss) gain





    (947,912)





    297,237

    COMPREHENSIVE LOSS



    $

    (4,451,639)



    $

    (106,699)

    LESS: COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO NON-CONTROLLING

    INTEREST





    (34)





    16

    COMPREHENSIVE LOSS ATTRIBUTABLE TO TIAN RUIXIANG HOLDINGS

    LTD ORDINARY SHAREHOLDERS



    $

    (4,451,605)



    $

    (106,715)















    NET LOSS PER ORDINARY SHARE ATTRIBUTABLE TO TIAN RUIXIANG HOLDINGS

    LTD ORDINARY SHAREHOLDERS:













    Basic and diluted



    $

    (0.28)



    $

    (0.06)















    WEIGHTED AVERAGE ORDINARY SHARES OUTSTANDING:













    Basic and diluted





    12,298,929





    6,560,497

     

     

    TIAN RUIXIANG HOLDINGS LTD AND SUBSIDIARIES

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (IN U.S. DOLLARS)







    For the Six Months Ended April 30, 





    2022



    2021















    CASH FLOWS FROM OPERATING ACTIVITIES:













    Net loss



    $

    (3,503,727)



    $

    (403,936)

    Adjustments to reconcile net loss to













    net cash (used in) provided by operating activities:













    Depreciation expense and amortization of intangible assets





    12,497





    13,492

    Amortization of right-of-use assets





    168,618





    132,622

    Stock-based compensation and service expense





    2,588,828





    —

    Changes in operating assets and liabilities:













    Accounts receivable





    221,522





    923,218

    Security deposit





    16,880





    4,495

    Interest receivable





    (73,972)





    —

    Due from related party





    (2,578)





    —

    Other assets





    292,661





    134,880

    Taxes payable





    21,814





    (41,633)

    Salary payable





    109,129





    218,031

    Accrued liabilities and other payables





    182,255





    250,097

    Due to related parties





    (2,578)





    10,071

    Operating lease liabilities - related party





    —





    (6,141)

    Operating lease liabilities





    (106,957)





    (141,073)















    NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES





    (75,608)





    1,094,123















    CASH FLOWS FROM INVESTING ACTIVITIES:













    Purchase of property and equipment





    (2,436)





    —















    NET CASH USED IN INVESTING ACTIVITIES





    (2,436)





    —















    CASH FLOWS FROM FINANCING ACTIVITIES













    Proceeds from note payable





    —





    75,165

    Proceeds from related parties' borrowings





    233,811





    1,652,137

    Repayments for related parties' borrowings





    (233,811)





    (1,863,143)

    Proceeds from initial public offering





    —





    12,300,000

    Disbursements for initial public offering costs





    —





    (1,449,770)















    NET CASH PROVIDED BY FINANCING ACTIVITIES





    —





    10,714,389















    EFFECT OF EXCHANGE RATE ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH





    (955,185)





    238,374















    NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH





    (1,033,229)





    12,046,886















    CASH, CASH EQUIVALENTS AND RESTRICTED CASH  - beginning of period





    30,843,641





    6,923,495















    CASH, CASH EQUIVALENTS AND RESTRICTED CASH - end of period



    $

    29,810,412



    $

    18,970,381















    SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:













    Cash paid for:













    Interest



    $

    22



    $

    —

    Income taxes



    $

    —



    $

    597















    NON-CASH INVESTING AND FINANCING ACTIVITIES













    Payments made by related parties on the Company's behalf



    $

    —



    $

    267,610















    RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH













    Cash and cash equivalents at beginning of period



    $

    30,024,372



    $

    6,137,689

    Restricted cash at beginning of period





    819,269





    785,806

    Total cash, cash equivalents and restricted cash at beginning of period



    $

    30,843,641



    $

    6,923,495















    Cash and cash equivalents at end of period



    $

    29,015,368



    $

    18,160,102

    Restricted cash at end of period





    795,044





    810,279

    Total cash, cash equivalents and restricted cash at end of period



    $

    29,810,412



    $

    18,970,381

     

     

     

    Cision View original content:https://www.prnewswire.com/news-releases/tian-ruixiang-holdings-ltd-reports-financial-results-for-the-six-months-ended-april-30-2022-301661610.html

    SOURCE TIAN RUIXIANG Holdings Ltd

    Get the next $TIRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TIRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TIRX
    SEC Filings

    View All

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    3/4/26 9:15:15 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form NT 20-F filed by TIAN RUIXIANG Holdings Ltd

    NT 20-F - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    3/4/26 6:03:53 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/27/26 9:15:43 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TIAN RUIXIANG Holdings Ltd. Announces Receipt of Nasdaq Suspension and Delisting Notification

    BEIJING, March 04, 2026 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX) (the "Company" or "TRX") today announced that it received notification from Nasdaq Staff which determined that as of February 27, 2026, the Company's securities had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the "Low Priced Stocks Rule") and this matter serves as an additional basis for delisting the Company's securities from The Nasdaq Stock Market. Pursuant to Listing Rule 5815(a)(1)(B)(ii)(e), the Company's securities will be delisted from the Capital Market. In that r

    3/4/26 9:00:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG UNVEILS GROUNDBREAKING LAUNCHING OF INDUSTRY-FIRST BTC STAKING WITH AI-DRIVEN YIELD INSURANCE AND FULLY AUTONOMOUS AI INSURANCE AGENT FOR INSTANT UNDERWRITING AND CLAIMS SETTLEMENT

    BEIJING, CHINA, March 04, 2026 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Limited ("TIRX" or the "Company") (NASDAQ:TIRX), a visionary leader at the cutting-edge intersection of digital asset finance, artificial intelligence ("AI"), and next-generation insurance technology, today announced a historic dual-product launch poised to redefine stability, efficiency, and value creation in the global Web3 and decentralized finance ecosystem. In a bold leap forward for secure digital asset yield generation, the Company is introducing two transformative, industry-first solutions scheduled for official rollout in the coming quarter: A premium Bitcoin ("BTC") staking program empowered by proprieta

    3/4/26 9:00:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG UNLEASHING HISTORIC CATALYSTS: 1:50 REVERSE SPLIT MARCH 16; DUE DILIGENCE COMPLETED FOR 30,000 BITCOIN INFUSION AND AI INSURANCE BROKERAGE ACQUISITION, TARGETED CLOSING IN Q2–Q3 2026

    BEIJING, March 03, 2026 (GLOBE NEWSWIRE) -- Tian Ruixiang Holdings Limited (NASDAQ:TIRX) today announces a seismic, paradigm-shifting set of catalysts designed to ignite explosive growth, redefine its market valuation, and deliver unprecedented shareholder value. The Company confirms its 1:50 reverse stock split will be fully effective March 16, 2026, marking a critical milestone to strengthen liquidity, institutional eligibility, and long-term price momentum. In a landmark development, TIRX has successfully completed full due diligence for two transformative transactions: - A strategic corporate treasury infusion of 30,000 Bitcoin; - The acquisition of a high-growth AI-powered insuran

    3/3/26 9:30:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Financials

    Live finance-specific insights

    View All

    Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, "From Traditional Insurance Broker to Tech-Based Health Insurance Innovator"

    ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ:TIRX) titled, "From Traditional Insurance Broker to Tech- Based Health Insurance Innovator". The report can be accessed here. Access to China's growing health insurance market. On June 30, 2025, Chinese insurance broker Tian Ruixiang Holdings Limited completed the acquisition of Ucare, which describes itself as the only cloud-based healthcare value assessment and insurance risk control SaaS platform in China, for total all-stock consideration of $150 million. Ucare's wealth of AI-driven analytics st

    8/7/25 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Completes Acquisition of Ucare Inc., Marking Strategic Expansion into AI-Powered Health Insurance Solutions

    BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX's strategy to expand into in-hospital distribution channels and capture new growth opportunities within the health insurance sector. As part of the closing, TRX has issued 101,486,575 Class A ordinary shares, each with a par value of US$0.025

    6/30/25 3:05:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

    BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

    8/16/24 4:15:15 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Leadership Updates

    Live Leadership Updates

    View All

    TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

    BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

    5/30/25 6:10:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by TIAN RUIXIANG Holdings Ltd

    SC 13G/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    11/13/24 11:16:48 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D filed by TIAN RUIXIANG Holdings Ltd

    SC 13D - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:15:45 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by TIAN RUIXIANG Holdings Ltd (Amendment)

    SC 13D/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:08:20 AM ET
    $TIRX
    Specialty Insurers
    Finance